WHAT WE DO

Pre-clinical Bioactivity Testing in a whole organism

Purpose-built to de-risk product development by delivering faster, lower-cost, and regulatorily lighter evidence than traditional animal or clinical studies.

What We Test / Validate

  •  Metabolism: Analysis of glucose metabolism and general metabolic function.
  • Inflammation & Neuroinflammation: High resolution and functional visualisation of anti-inflammatory effects.
  • Cognition: Behavioural and functional endpoints linked to cognitive function.

We focus on measuring bioactivity and functional signals; we do not diagnose, treat, or claim to cure diseases.

Why Zebrafish (and Complementary Models)?

  • Whole-organism biology: Captures multi-system interactions missed by cell-only assays.
  • Speed & throughput: Efficiently screens multiple doses/formulations.
  • Ethical & practical: Widely adopted pre-clinical model supporting the 3Rs.
  • Translational signals: Informative for mechanism exploration and next-stage study design.

Typical Deliverables

  • Study design & protocol aligned to your hypothesis and target claims language.
  • Dose-response and endpoint data (raw + analyzed) with statistics and visualizations. Analysis of synergistic or additive effects.
  • Clear readouts (e.g., effect size, directionality, consistency) for go/no-go decisions.
  • Executive summary for non-technical stakeholders; technical appendix for R&D.
  • Confidentiality/IP respected; data and methods documented for internal review.

ENGAGEMENT WORKFLOW

  • Discovery call

    Define hypothesis, endpoints, formulations, and timelines.

  • Protocol & quote

    Scope, assay selection, and milestones.

  • Sample receipt & run

    Controlled execution and QC.

  • Results & readout

    Debrief with scientists; recommendations for next steps.

  • Follow-on options

    Formulation refinement, dose optimization, or pilot clinical planning with partners.

1 5

COMMERCIAL ADVANTAGES

FASTER TO EVIDENCE than traditional rodent studies.

LOWER REGULATORY requirements than rodent/clinical studies.

COST-EFFECTIVE screening to prioritize the most promising candidates.

INDEPENDENT VALIDATION to support your claims strategy and investor communications.